Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
173.0200 2.07 (1.21%)
NSE Sep 03, 2025 15:31 PM
Volume: 945.4K
 

173.02
1.21%
StoxBox - BP Wealth
Marksans Pharma has entered into a Business Transfer Agreement with Tevapharm to acquire its business relating to the manufacture and supply of bulk pharmaceutical formulations in Goa. The company plans to manufacture tablets, hard and soft gel capsules, ointments, gummies, and creams from the new capacity.
Marksans Pharma Ltd. has lost -23.05% in the last 1 Month
More from Marksans Pharma Ltd.
Recommended